SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950116-04-000880
Filing Date
2004-03-18
Accepted
2004-03-18 18:04:13
Documents
1
Period of Report
2004-03-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 p330912_ex.html 3  
1 FORM 3 p330912_ex.xml 3 1478
  Complete submission text file 0000950116-04-000880.txt   3399
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Issuer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 201 BRIDGELAND AVE TORONTO ONTARIO CANDA M6A 1Y A6 00000
Business Address 201 BRIDGELAND AVE TORONTO ONTARIO CANADA M6A 1 A6 00000 416 246 4000
MCGEE BRIAN (Reporting) CIK: 0001284144 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-25169 | Film No.: 04678551